These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4604487)

  • 1. Fosfomycin-resistant mutant of Escherichia coli.
    Wu HC; Venkateswaran PS
    Ann N Y Acad Sci; 1974 May; 235(0):587-92. PubMed ID: 4604487
    [No Abstract]   [Full Text] [Related]  

  • 2. The mechanism of action of fosfomycin (phosphonomycin).
    Kahan FM; Kahan JS; Cassidy PJ; Kropp H
    Ann N Y Acad Sci; 1974 May; 235(0):364-86. PubMed ID: 4605290
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacteriostatic activities of alpha-glyceryl and alpha-glycidyl phenyl ethers for Escherichia coli B.
    Kelpatrick KA; Lambooy JP
    Proc Soc Exp Biol Med; 1967 Oct; 126(1):237-40. PubMed ID: 4864023
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell division and permeability of unbalanced envelope mutants of Escherichia coli K12.
    Normark S; Wolf-Watz H
    Ann Microbiol (Paris); 1974 Sep; 125 B(2):211-26. PubMed ID: 4617545
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro development of resistance to fosfomycin.
    Dulaney EL; Ruby CL
    J Antibiot (Tokyo); 1977 Mar; 30(3):252-61. PubMed ID: 324957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of flavomycin on episomal resistant bacteria].
    Lebek G
    Zentralbl Veterinarmed B; 1972 Aug; 19(7):532-9. PubMed ID: 4567177
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin.
    Eggert US; Ruiz N; Falcone BV; Branstrom AA; Goldman RC; Silhavy TJ; Kahne D
    Science; 2001 Oct; 294(5541):361-4. PubMed ID: 11520949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phosphomycin in the treatment of bacterial infections].
    Bonora V; Lozano C; Santos M; Paz MM; Gobernado M
    Rev Clin Esp; 1974 Nov; 135(3):269-73. PubMed ID: 4450056
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of conjugation and recombination in bacteria. II. Recombination deficiency in edeine-resistant Hfr strains.
    Wlodarczyk M; Piekarowicz A; Borowski E; Kunicki-Goldfinger JH
    Acta Microbiol Pol; 1968; 17(2):121-7. PubMed ID: 4174112
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolation and characterization of a mocimycin resistant mutant of Escherichia coli with an altered elongation factor EF-Tu.
    van de Klundert JA; den Turk E; Borman AH; van der Meide PH; Bosch L
    FEBS Lett; 1977 Sep; 81(2):303-7. PubMed ID: 336393
    [No Abstract]   [Full Text] [Related]  

  • 11. Two kinds of mutants defective in multiple carbohydrate utilization isolated from in vitro fosfomycin-resistant strains of Escherichia coli K--12.
    Tsuruoka T; Miyata A; Yamada Y
    J Antibiot (Tokyo); 1978 Mar; 31(3):192-201. PubMed ID: 206529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotics as an aid in the studies of cell division regulation in Escherichia coli].
    Hoffmann B
    Zentralbl Bakteriol Orig A; 1974; 228(1):223-32. PubMed ID: 4154671
    [No Abstract]   [Full Text] [Related]  

  • 13. R-factor-mediated resistance to tetracycline in Escherichia coli K12: an R-factor with a mutation to temperature-sensitive tetracycline resistance.
    Young TW; Hubball SJ
    Biochem Biophys Res Commun; 1976 May; 70(1):117-24. PubMed ID: 776184
    [No Abstract]   [Full Text] [Related]  

  • 14. Biosynthesis of murein lipoprotein in Escherichia coli: effects of 3,4-dihydroxybutyl-1-phosphonate.
    Chattopadhyay PK; Engel R; Tropp BE; Wu HC
    J Bacteriol; 1979 Jun; 138(3):944-8. PubMed ID: 378946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of new and novel beta-lactam antibiotics.
    Aoki H; Kunugita K; Hosoda J; Imanaka H
    Jpn J Antibiot; 1977 Dec; 30 Suppl():207-17. PubMed ID: 349191
    [No Abstract]   [Full Text] [Related]  

  • 16. [Topical use of phosphonomycin].
    Raab W; Windisch J
    Arch Dermatol Forsch; 1973 Jan; 246(1):27-34. PubMed ID: 4120915
    [No Abstract]   [Full Text] [Related]  

  • 17. How is fosfomycin resistance developed in Escherichia coli?
    Cattoir V; Guérin F
    Future Microbiol; 2018 Dec; 13():1693-1696. PubMed ID: 30526061
    [No Abstract]   [Full Text] [Related]  

  • 18. Seminalplasmin, an antimicrobial protein from bovine seminal plasma, inhibits peptidoglycan synthesis in Escherichia coli.
    Chitnis SN; Prasad KS
    FEMS Microbiol Lett; 1990 Nov; 60(3):281-4. PubMed ID: 2083841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of fosfomycin against Pasteurella.
    Frost BM; Valiant ME; Benson L; Dulaney EL
    Avian Dis; 1974; 18(4):578-89. PubMed ID: 4139947
    [No Abstract]   [Full Text] [Related]  

  • 20. Genes, enzymes and membrane proteins of the nitrate respiration system of Escherichia coli.
    Rolfe B; Onodera K
    J Membr Biol; 1972; 9(2):195-207. PubMed ID: 4563590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.